24161-38-4 Usage
Uses
Used in Pharmaceutical Industry:
Benzeneacetic acid, 5-chloro-2-hydroxy-, is used as an intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs) for its potential to contribute to the development of new medications that alleviate pain, reduce inflammation, and lower fever.
Used in Antimicrobial Agents Development:
Due to its antifungal and antibacterial properties, benzeneacetic acid, 5-chloro-2-hydroxy-, is used as a potential candidate for the development of new antimicrobial agents, which can help combat resistant strains of bacteria and fungi.
Used in Dyes and Pigments Production:
Benzeneacetic acid, 5-chloro-2-hydroxy-, is utilized in the production of dyes and pigments, contributing to the coloration and stability of various products in the textile, paint, and printing industries.
Used in Chemical Industry for Various Applications:
Benzeneacetic acid,5-chloro-2-hydroxyis also employed in the chemical industry for a range of applications, including the synthesis of other organic compounds and the development of new chemical processes, highlighting its versatility and importance in research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 24161-38-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,1,6 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 24161-38:
(7*2)+(6*4)+(5*1)+(4*6)+(3*1)+(2*3)+(1*8)=84
84 % 10 = 4
So 24161-38-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H7ClO3/c9-6-1-2-7(10)5(3-6)4-8(11)12/h1-3,10H,4H2,(H,11,12)
24161-38-4Relevant academic research and scientific papers
Piperazinyl CCR1 antagonists-optimization of human liver microsome stability
Brown, Matthew F.,Bahnck, Kevin B.,Blumberg, Laura C.,Brissette, William H.,Burrell, Sara A.,Driscoll, James P.,Fedeles, Flavia,Fisher, Michael B.,Foti, Robert S.,Gladue, Ronald P.,Guzman-Martinez, Aikomari,Hayward, Matthew M.,Lira, Paul D.,Lillie, Brett M.,Lu, Yi,Lundquist, Greg D.,McElroy, Eric B.,McGlynn, Molly A.,Paradis, Timothy J.,Poss, Christopher S.,Roache, James H.,Shavnya, Andrei,Shepard, Richard M.,Trevena, Kristen A.,Tylaska, Laurie A.
, p. 3109 - 3112 (2008/03/13)
The synthesis, biological activity, and pharmacokinetic profile of CCR1 antagonists are described.
Methods of using piperazine derivatives
-
, (2008/06/13)
The present invention relates to compounds of the formula I and the pharmaceutically acceptable forms thereof; wherein X, Y, a, b, c, d, R1, R2, R3, R4 and R5 are as defined herein. Moreover, the present invention is also directed at pharmaceutical compositions comprising a compound of the formula I and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed at methods of using the herein described compounds and compositions for treating or preventing a disorder or condition that can be treated or prevented by antagonizing the CCR1 receptor in a mammal.
Novel sulfonic acid derivatives
-
, (2008/06/13)
A compound of the formula or the pharmaceutically acceptable salt thereof; wherein X, Y, a, b, c, d, R1, R2, R3 and R5 are as defined above useful to treat inflammation and other immune disorders.
